Toshihiko Kono
Overview
Explore the profile of Toshihiko Kono including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A
Arch Osteoporos
. 2020 Jan;
15(1):7.
PMID: 31898803
Here, we report the case of a 69-year-old female who discontinued denosumab to undergo dental treatment. She subsequently suffered rebound-associated vertebral fractures (RVFs) twice. Denosumab is approved in several countries...
2.
Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A
JBMR Plus
. 2018 Oct;
2(5):289-294.
PMID: 30283910
There is no consensus on an optimal treatment after daily teriparatide (TPTD). We performed a prospective, randomized, open-label, 12-month trial to investigate the efficacy of follow-up treatment after daily TPTD...
3.
Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A
Clin Drug Investig
. 2017 Mar;
37(6):551-557.
PMID: 28247298
Introduction: Little is known about the efficacy of osteoporosis medication in patients with low levels of walking state, namely, influence by immobilization levels. We retrospectively compared the efficacy of the...
4.
Niimi R, Kono T, Nishihara A, Hasegawa M, Kono T, Sudo A
Calcif Tissue Int
. 2016 May;
99(3):282-8.
PMID: 27206528
The degree of correlation between the first 12 months and the latter 12 months of increased bone mineral density (BMD) with teriparatide treatment is unknown. We retrospectively investigated the correlation...
5.
Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, et al.
J Am Geriatr Soc
. 2016 Apr;
64(4):911-2.
PMID: 27100602
No abstract available.
6.
Maeda T, Sakurai R, Nakagawa K, Morishima K, Maekawa M, Furumoto K, et al.
J Cardiothorac Vasc Anesth
. 2015 Dec;
30(3):599-605.
PMID: 26708696
Objectives: First, to examine the perioperative association between increased cardiac index (CI) measured using three-dimensional echocardiography (CI3D), two-dimensional echocardiography (CI2D), and FloTrac/Vigileo (CIFT) (Edwards Lifesciences, Irvine, CA) after cardiac resynchronization...
7.
Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, et al.
J Bone Miner Res
. 2014 Aug;
30(2):225-31.
PMID: 25156261
Femoral cortical thickening has been mentioned in reports of atypical subtrochanteric/femoral shaft (ST/FS) fractures, which are associated with long-term bisphosphonate (BP) use. However, whether thickening precedes BP use or results...
8.
Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, et al.
Bone
. 2014 Jun;
66:26-30.
PMID: 24909538
Introduction: Several factors associated with bone mineral density (BMD) increase are reported with daily teriparatide treatment, but there has been no systematic analysis to summarize these associations. The purpose of...